In the last week, the United States market has stayed flat, yet it has experienced a remarkable 37% increase over the past year with earnings forecast to grow by 15% annually. In such an environment, identifying stocks that are not only poised for growth but also remain underappreciated can offer unique opportunities for investors seeking potential in undiscovered gems.
Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
---|---|---|---|---|
Eagle Financial Services | 169.49% | 12.30% | 1.92% | ★★★★★★ |
Morris State Bancshares | 17.84% | 4.83% | 6.58% | ★★★★★★ |
Franklin Financial Services | 222.36% | 5.55% | -1.86% | ★★★★★★ |
First Ottawa Bancshares | 85.49% | 7.25% | 25.81% | ★★★★★★ |
First Northern Community Bancorp | NA | 7.65% | 11.17% | ★★★★★★ |
Omega Flex | NA | 1.31% | 3.88% | ★★★★★★ |
Teekay | NA | -6.48% | 55.79% | ★★★★★★ |
ASA Gold and Precious Metals | NA | 7.11% | -35.88% | ★★★★★☆ |
Valhi | 38.71% | 2.57% | -19.76% | ★★★★★☆ |
FRMO | 0.13% | 19.43% | 29.70% | ★★★★☆☆ |
Click here to see the full list of 227 stocks from our US Undiscovered Gems With Strong Fundamentals screener.
Let's explore several standout options from the results in the screener.
Simply Wall St Value Rating: ★★★★★★
Overview: IRADIMED CORPORATION specializes in the development, manufacturing, marketing, and distribution of MRI-compatible medical devices and related accessories, disposables, and services both domestically and internationally with a market cap of $665.80 million.
Operations: IRADIMED generates revenue primarily from its patient monitoring equipment segment, totaling $69.48 million. The company operates with a market cap of approximately $665.80 million.
IRADIMED, a nimble player in the medical equipment sector, has shown impressive growth with earnings up 26.9% over the past year, outpacing industry averages. The company boasts a debt-free balance sheet and a price-to-earnings ratio of 36x, slightly below the sector's average of 36.7x. Recent developments include an anticipated revenue boost from its new IV pump and Monitor business expansion. Despite these positives, challenges such as reliance on domestic markets and potential FDA delays could impact future performance. With shares currently priced at US$52.55, analysts see potential upside to US$60 based on projected growth trends.
Simply Wall St Value Rating: ★★★★★★
Overview: Southern Missouri Bancorp, Inc. serves as the bank holding company for Southern Bank, offering a range of banking and financial services to individuals and corporate clients in the United States, with a market capitalization of $672.34 million.
Operations: Southern Missouri Bancorp generates revenue primarily through interest income from loans and investments, supplemented by non-interest income such as fees for services. The company focuses on managing its net profit margin, which is currently at 28.5%.
Southern Missouri Bancorp, with assets totaling $4.7 billion and equity of $505.6 million, stands out for its robust financial health. The company has total deposits of $4 billion against loans of $3.9 billion, showcasing a solid balance sheet structure. Its allowance for bad loans is sufficient at 0.2% of total loans, indicating prudent risk management practices. Despite significant insider selling recently, the stock trades at 37% below its estimated fair value, suggesting potential undervaluation in the market. With earnings growth surpassing industry averages and primarily low-risk funding sources comprising 96% of liabilities, Southern Missouri Bancorp presents an intriguing investment opportunity amidst recent challenges like increased credit loss provisions and noninterest expenses.
Simply Wall St Value Rating: ★★★★★★
Overview: 1st Source Corporation is a bank holding company for 1st Source Bank, offering commercial and consumer banking, trust and wealth advisory services, and insurance products to individual and business clients, with a market cap of $1.48 billion.
Operations: 1st Source generates revenue primarily through its commercial banking segment, which accounts for $369.01 million.
1st Source, a financial entity with total assets of US$8.8 billion and equity of US$1.2 billion, demonstrates robust health with deposits at US$7.1 billion and loans totaling US$6.5 billion. The bank's allowance for bad loans is sufficient at 0.5%, indicating prudent risk management practices within the industry context where its earnings growth of 1.6% outpaces the broader sector's -13.8%. Despite forecasts suggesting a potential average earnings dip of 0.9% over the next three years, it trades significantly below estimated fair value by 61%, providing an attractive valuation proposition for investors considering its primarily low-risk funding structure and high-quality past earnings performance.
Assess 1st Source's past performance with our detailed historical performance reports.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqGM:IRMD NasdaqGM:SMBC and NasdaqGS:SRCE.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。